ICD-10-PCS XY0 New Technology: Extracorporeal Introduction
The ICD-10-PCS root operation Introduction (code XY0) in the New Technology section refers to the placement of a substance or device into the body through an extracorporeal approach. This operation involves introducing therapeutic agents or materials without direct insertion into a specific body cavity or organ.
The provided codes illustrate several applications of this extracorporeal introduction method. For example, code XY0VX83 describes the introduction of an Endothelial Damage Inhibitor to a Vein Graft, while XY0YX28 covers the combined introduction of Taurolidine Anti-infective and Heparin Anticoagulant. Additionally, code XY0YX37 documents the introduction of Nafamostat Anticoagulant, further demonstrating the variety of agents delivered via this approach. These codes are essential for accurately capturing innovative techniques that utilize extracorporeal routes for therapeutic purposes in the evolving field of new medical technologies.
List of ICD-10-PCS codes used to specify XY0 - Introduction (putting in or on a therapeutic, diagnostic, nutritional, physiological or prophylactic substance except blood or blood products). There are a total of 4 procedure codes in this section.
XY0 - New Technology, Extracorporeal, Introduction
XY0VX83 - Extracorporeal Introduction of Endothelial Damage Inhibitor to Vein Graft, New Technology Group 3
XY0YX28 - Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8
XY0YX37 - Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7
